Literature DB >> 19095666

Increased access to emergency contraception: why it may fail.

Laura Baecher1, Mark A Weaver, Elizabeth G Raymond.   

Abstract

BACKGROUND: To explore why increased access to emergency contraception (EC) failed to reduce pregnancies in a recent randomized controlled trial.
METHODS: We used multivariable logistic regression to identify risk factors for unintended pregnancy using data from a trial involving sexually active women (n = 1490, aged 14-24 years) randomly assigned to either increased access or standard access to EC. We used predictive modeling to generate estimated pregnancy risk scores for each participant. We then examined EC use among women at low or high baseline risk of pregnancy.
RESULTS: Gravidity, recent history of unprotected sex (within 14 days of enrollment to study) and lower aversion to pregnancy predicted unintended pregnancy. Women in the increased access group were more likely than women in the standard access group to use EC repeatedly. This difference was significantly stronger (P = 0.03) among low risk women than high risk women [Relative risk (RR) 10.0, 95% confidence interval (CI) 6.5-15.4 and RR 5.5, 95% CI 3.8-7.9, respectively].
CONCLUSIONS: Increased access to EC had a greater impact on women who were at lower baseline risk of pregnancy. This may explain in part why increased access to EC has had no measurable benefit in clinical trials.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19095666      PMCID: PMC2721726          DOI: 10.1093/humrep/den460

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  11 in total

1.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.

Authors:  D Moher; K F Schulz; D G Altman
Journal:  Lancet       Date:  2001-04-14       Impact factor: 79.321

2.  Emergency contraceptive pills: a simple proposal to reduce unintended pregnancies.

Authors:  J Trussell; F Stewart; F Guest; R A Hatcher
Journal:  Fam Plann Perspect       Date:  1992 Nov-Dec

3.  Patterns of emergency contraception use by age and ethnicity from a randomized trial comparing advance provision and information only.

Authors:  Terri L Walsh; Ron G Frezieres
Journal:  Contraception       Date:  2006-06-16       Impact factor: 3.375

4.  Emergency contraception.

Authors:  Anna Glasier
Journal:  BMJ       Date:  2006-09-16

5.  Advanced provision of emergency contraception to postnatal women in China makes no difference in abortion rates: a randomized controlled trial.

Authors:  Xiaoyu Hu; Linan Cheng; Xiaolin Hua; Anna Glasier
Journal:  Contraception       Date:  2005-08       Impact factor: 3.375

6.  Impact of increased access to emergency contraceptive pills: a randomized controlled trial.

Authors:  Elizabeth G Raymond; Felicia Stewart; Mark Weaver; Charles Monteith; Barbara Van Der Pol
Journal:  Obstet Gynecol       Date:  2006-11       Impact factor: 7.661

7.  Effect of advanced provision of emergency contraception on women's contraceptive behaviour: a randomized controlled trial.

Authors:  Sue S T Lo; Susan Y S Fan; P C Ho; Anna F Glasier
Journal:  Hum Reprod       Date:  2004-08-27       Impact factor: 6.918

8.  Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Task Force on Postovulatory Methods of Fertility Regulation.

Authors: 
Journal:  Lancet       Date:  1998-08-08       Impact factor: 79.321

9.  Effect of an emergency contraceptive pill intervention on pregnancy risk behavior.

Authors:  Elizabeth G Raymond; Mark A Weaver
Journal:  Contraception       Date:  2008-03-21       Impact factor: 3.375

10.  Attitude and behavior effects in a randomized trial of increased access to emergency contraception.

Authors:  Mark A Weaver; Elizabeth G Raymond; Laura Baecher
Journal:  Obstet Gynecol       Date:  2009-01       Impact factor: 7.661

View more
  1 in total

1.  Twelve-month follow-up of advance provision of emergency contraception among teenage girls in Sweden-a randomized controlled trial.

Authors:  Maria Ekstrand; Tanja Tydén; Elisabeth Darj; Margareta Larsson
Journal:  Ups J Med Sci       Date:  2013-11       Impact factor: 2.384

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.